- Home
- SNT vs DXR Comparison
SNT vs DXR Comparison
Compare SNT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNT | DXR |
|---|---|---|
| Founded | 1965 | 1970 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 71.4M |
| IPO Year | 2023 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SNT | DXR |
|---|---|---|
| Price | $2.97 | $9.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 22.5K | 11.9K |
| Earning Date | 05-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ $19.22 | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.75 | $7.10 |
| 52 Week High | $5.34 | $14.76 |
Technical Indicators
Market Signals| Indicator | SNT | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 52.36 |
| Support Level | $2.78 | $10.00 |
| Resistance Level | $3.19 | $10.49 |
| Average True Range (ATR) | 0.15 | 0.43 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 38.79 | 100.00 |
Price Performance
Historical ComparisonAbout SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.